Comparative Effects of Bariatric Surgery Techniques on Cardiometabolic Indices: A Cohort Study in Shiraz, Iran
This retrospective cohort study in Shiraz, Iran, found that while sleeve gastrectomy and Roux-en-Y gastric bypass achieved comparable weight loss and improvements in most cardiometabolic indices over 12 months, RYGB resulted in a significantly greater reduction in the lipoprotein combine index (LCI).
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
Obesity is more than just extra weight; it is a systemic condition where the body accumulates too much fat, often settling dangerously around the organs in the abdomen. This excess fat does not sit idle. It acts like a constant source of inflammation and disrupts the way the body handles sugar and fats in the blood, creating a perfect storm for heart disease, high blood pressure, and diabetes. For many people with severe obesity, diet and exercise alone are not enough to reverse these risks. In these cases, bariatric surgery, which physically alters the digestive system to help people lose weight, has become a powerful tool. While the surgery is known to help patients shed pounds, doctors and scientists are still working to understand exactly how different types of operations affect the body's internal chemistry. Specifically, they want to know if one surgical method is better than another at cleaning up the specific markers that signal heart trouble, beyond just the number on the scale.
In a recent study conducted in Shiraz, Iran, researchers set out to compare two of the most common weight-loss surgeries: sleeve gastrectomy and Roux-en-Y gastric bypass. The first procedure, sleeve gastrectomy, involves removing a large portion of the stomach to leave a smaller, tube-shaped organ. The second, Roux-en-Y gastric bypass, is a more complex operation that creates a small stomach pouch and reroutes the intestines to bypass a section of the digestive tract. The team followed 139 patients who had undergone one of these two procedures, tracking their health for a full year after surgery. They did not just look at how much weight the patients lost; they measured a wide array of internal health indicators, including blood sugar levels, cholesterol, and several newer, more sensitive calculations that estimate how much fat is stored around the organs and how likely a person is to develop heart disease.
The results showed that both surgeries were highly effective at helping patients lose weight. On average, the entire group lost about 34 percent of their starting body weight and more than 80 percent of their excess weight. When the researchers compared the two groups directly, they found that the amount of weight lost was nearly identical, regardless of which surgery the patient had received. The patients who had the sleeve gastrectomy lost weight at the same rate as those who had the gastric bypass. This suggests that, in terms of pure weight reduction, neither technique holds a clear advantage over the other in the first year after the operation.
The story becomes more interesting when looking at the internal health markers. For almost every measure of heart and metabolic health, both surgeries produced dramatic improvements. Blood sugar levels dropped, bad cholesterol decreased, and the body's ability to handle fats improved significantly for everyone. The researchers calculated several complex indices that combine different blood and body measurements to predict cardiovascular risk, and nearly all of these numbers moved in a healthy direction after surgery. There was one notable exception: a specific measurement called the weight-adjusted waist index, which looks at waist size relative to weight, did not change significantly for either group. This suggests that while the body loses weight and fat, the relationship between waist size and total body mass might not shift in the way scientists had hoped, or at least not within the first year.
However, there was one specific area where the two surgeries differed. The researchers found that patients who underwent the Roux-en-Y gastric bypass saw a significantly greater reduction in a marker called the lipoprotein combine index. This index is a calculation that reflects how well the body is managing its fats and cholesterol. While both groups improved, the bypass group saw a deeper drop in this specific risk factor compared to the sleeve group. For all the other heart and metabolic markers measured, including those related to insulin resistance and fat accumulation, the improvements were statistically similar between the two groups. The study also found that the more weight a patient lost, the better their scores became on several of these internal health measures, particularly those related to body fat distribution and triglyceride levels.
Ultimately, the study concludes that both sleeve gastrectomy and Roux-en-Y gastric bypass are powerful tools for improving the overall health of people with severe obesity. They produce comparable weight loss and similar improvements in most aspects of heart and metabolic health. The only clear distinction found was that the gastric bypass led to a slightly better outcome for one specific cholesterol-related marker. For the vast majority of patients, the choice between these two procedures may not depend on which one offers a superior metabolic reset, but rather on other factors such as individual health history or surgical risk, since both methods successfully turn the tide against the dangerous effects of obesity.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.